Market research
SHL.F Siemens Healthineers AG
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 45B
- P/E ratio
- 20.57
- Analyst target
- 45.095
- Dividend yield
- 2.5%
- Beta
- 0.83
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- DE000SHL1006
- Market cap
- 45B
- P/E ratio
- 20.57
- Analyst target
- 45.095
- Dividend yield
- 2.5%
- Beta
- 0.83
About
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS to increase product lifecycle with industrial AI. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SHL.F discussion.
5 years, 5 months ago
Siemens Healthineers AG is currently in a long term uptrend where the price is trading 20.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
Siemens Healthineers AG's total revenue rose by 7.8% to $4B since the same quarter in the previous year.
Its net income has increased by 43.5% to $432M since the same quarter in the previous year.
Finally, its free cash flow grew by 173.8% to $668M since the same quarter in the previous year.
Based on the above factors, Siemens Healthineers AG gets an overall score of 5/5.